214390 — Kyongbo Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Kyongbo Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	9,404	-7,495	611	2,974	4,639
Depreciation
Amortisation
Non-Cash Items	3,720	3,855	2,089	7,342	6,017
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-4,917	8,852	-4,508	-17,171	-22,915
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	20,795	17,968	10,127	4,844	149
Capital Expenditures	-12,437	-18,324	-13,184	-10,877	-13,175
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-7,241	2,150	-1,693	-3,391	-1,458
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-19,678	-16,174	-14,877	-14,268	-14,633
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	4,418	-9,222	6,589	7,159	13,868
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	4,670	-7,149	2,058	-1,871	-349